MCP Sign the guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M600443-MCP200 on February 22, 2007.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M600443-MCP200v1
M600443-MCP200v2
6/6/1007    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunner, Y.
Right arrow Articles by Sanchez, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunner, Y.
Right arrow Articles by Sanchez, J.-C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 6:1007-1017, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

Proteomics Analysis of Insulin Secretory Granules*,S

Yannick Brunner{ddagger}, Yohann Couté{ddagger}, Mariella Iezzi{ddagger}, Michelangelo Foti§, Mitsonuri Fukuda, Denis F. Hochstrasser{ddagger},||, Claes B. Wollheim§ and Jean-Charles Sanchez{ddagger},**

From the {ddagger} Biomedical Proteomics Research Group and § Department of Cell Physiology and Metabolism, University Medical Center, 1211 Geneva 4, Switzerland, Department of Developmental Biology and Neurosciences, Tohoku University, Sendai 980-8578 Japan, and || Central Clinical Chemistry Laboratory, Geneva University Hospital, 1211 Geneva 14, Switzerland


   ABSTRACT
TOP
 ABSTRACT
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Insulin secretory granules (ISGs) are cytoplasmic organelles of pancreatic ß-cells. They are responsible for the storage and secretion of insulin. To date, only about 30 different proteins have been clearly described to be associated with these organelles. However, data from two-dimensional gel electrophoresis analyses suggested that almost 150 different polypeptides might be present within ISGs. The elucidation of the identity and function of the ISG proteins by proteomics strategies would be of considerable help to further understand some of the underlying mechanisms implicated in ISG biogenesis and trafficking. Furthermore it should give the bases to the comprehension of impaired insulin secretion observed during diabetes. A proteomics analysis of an enriched insulin granule fraction from the rat insulin-secreting cell line INS-1E was performed. The efficacy of the fractionation procedure was assessed by Western blot and electron microscopy. Proteins of the ISG fraction were separated by SDS-PAGE, excised from consecutive gel slices, and tryptically digested. Peptides were analyzed by nano-LC-ESI-MS/MS. This strategy identified 130 different proteins that were classified into four structural groups including intravesicular proteins, membrane proteins, novel proteins, and other proteins. Confocal microscopy analysis demonstrated the association of Rab37 and VAMP8 with ISGs in INS-1E cells. In conclusion, the present study identified 130 proteins from which 110 are new proteins associated with ISGs. The elucidation of their role will further help in the understanding of the mechanisms governing impaired insulin secretion during diabetes.

Insulin is a key molecule for the organism because it regulates glucose homeostasis (1), lipid and protein metabolism (2, 3), brain function (4), and cell survival (5). Pancreatic ß-cells are the functional units responsible for the storage and secretion of insulin (6). These cells are able to adapt their rate of insulin secretion to blood glucose variations (7). Insulin is initially translated as a proinsulin precursor in the endoplasmic reticulum (ER),1 is then transported from the ER to the Golgi apparatus, and crosses the Golgi network before being sorted into clathrin-coated immature insulin secretory granules (ISGs). The acidification of the lumen of immature ISGs through the action of ATPase proton pumps coincides with the cleavage of proinsulin into insulin and peptide C (8–10). These biochemical modifications trigger the maturation to mature ISGs. After glucose stimulation, mature ISGs release their insulin content into the extracellular space by exocytosis (11). One primary ß-cell contains around 10,000 ISGs; however, only 100–200 ISGs are capable to quickly release their insulin content in response to an increased intracellular [Ca2+] (12). The majority of ISGs belong to a reserve pool and must undergo several ATP-dependent reactions to become competent for final exocytosis (11, 13). Suppression of ISG-associated proteins such as vesicle-associated membrane protein 2 (VAMP2) or Rab3a affects insulin secretion demonstrating the functional importance of these proteins in the regulated insulin release (14, 15).

Whether insulin resistance or insulin secretion defects are primary in the development of type 2 diabetes has been a highly debated topic, and there is no consensus. However, it is clear that overt type 2 diabetes only occurs when the insulin output from the pancreatic islets fails to match the insulin requirement as a result of the insulin resistance (16). It is not clear whether the primary decline in insulin secretion results from a reduction in the number of ß-cells, a progressive dysfunction of some of the ß-cells, or a combination of both (17). The molecular mechanisms leading to insulin secretion impairment may partly be due to the modulation of the expression of several key ISG proteins. Their identification would provide a better picture of the events involved in the onset of diabetes. So far only about 30 proteins have been clearly described to be associated with ISGs. However, according to 2-DE gel analysis, Hutton (18) suggested that ISGs potentially contain more than 150 polypeptides. To date the identity of these proteins remains to be determined.

This work presents for the first time a comprehensive picture of the ISG proteome from the rat ß-cell line INS-1E. This cell line has previously proven useful for the elucidation of secretory granule protein function (19, 20). The ISG fraction was obtained by a two-step subcellular fractionation strategy, its protein content was separated by SDS-PAGE, and 130 proteins were identified by tandem mass spectrometry. Finally immunofluorescence experiments showed the newly found presence of Rab37 and VAMP8 proteins on ISGs.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Materials—
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich and were of the highest purity available. CH3CN was purchased from Biosolve (Westford, MA). Percoll solution was obtained from GE Healthcare. Rabbit polyclonal antibody against betagranin was from Eurogentech (Seraing, Belgium), mouse monoclonal antibody against cathepsin L and pig polyclonal antibody against insulin were from Abcam (Cambridge, UK), rabbit polyclonal antibody against VAMP8 was from Synaptic System (Gottingen, Germany), mouse monoclonal antibody against GS-28 was from Calbiochem (EMB Biosciences), rabbit polyclonal antibody against lysosome-associated membrane protein 2 (Lamp2) was from Zymed Laboratories Inc.(Invitrogen), rabbit polyclonal antibody against cathepsin B was from Upstate (Chicago, IL), rabbit polyclonal antibody against calreticulin was a gift from Dr. K. H. Krause (University of Geneva, Geneva, Switzerland), rabbit polyclonal antibody against Glut2 was a gift from Dr. P. Meda (University of Geneva, Geneva, Switzerland), and rabbit polyclonal antibodies against Rab5 and cathepsin D were a gift from Dr. J. Gruenberg (University of Geneva, Geneva, Switzerland). Fluorescent dye-conjugated secondary antibodies (546nm anti-rabbit, 546nm anti-mouse, 488nm anti-rabbit, 488nm anti-mouse, and 488nm anti-pig) were from Fluoprobes (Chemie-Brunschwig, Basel, Switzerland). Insulin content was measured by ELISA (Mercodia, Uppsala, Sweden) according to the manufacturer's instructions.

Cell Culture and Transfection—
The INS-1E clone from the insulin-secreting cell line INS-1 was cultured in RPMI 1640 medium and other additions as described by Merglen et al. (21). INS-1E cells were transfected with LipofectamineTM 2000 (Invitrogen) according to the manufacturer's instructions. The mouse Rab37 cDNA (GenBankTM accession number AB232633) was amplified by PCR and subcloned into the BgIII/EcoRI site of pEGFP-C1 vector (Clontech) as described previously (22).

Subcellular Fractionation for Insulin Secretory Granules Purification—
ISGs were obtained by subcellular fractionation from INS-1E cells. All procedures were performed at 4 °C. Briefly about 8 x 108 INS-1E cells grown in 600-cm2 dishes were washed once with PBS and scraped in cold PBS. Cells were then homogenized in 15 ml of 0.27 M sucrose, 10 mM MOPS-Tris (pH 6.8) (SMT) by three strokes through a 21-gauge needle followed by three strokes through a 25-gauge needle. Cell debris and nuclei were removed by centrifugation for 5 min at 1000 x g. The supernatant was transferred to a new tube, and the remaining pellet was homogenized in 15 ml of SMT by three strokes through a 21-gauge needle followed by five strokes through a 25-gauge needle. The homogenate was centrifuged for 5 min at 1000 x g, and the resulting supernatant was pooled with the first one. The pooled supernatant was finally centrifuged for 10 min at 1000 x g to obtain the postnuclear supernatant (PNS). The PNS was then centrifuged at 24,700 x g for 20 min to separate organelles from the cytosol. The resulting pellet was resuspended in SMT, loaded on a discontinuous Nycodenz gradient composed of three layers (23.4, 8.8, and 4.4%) and centrifuged at 107,000 x g for 75 min. The Nycodenz enriched insulin granule fraction was recovered and loaded on a 27% Percoll solution, which was centrifuged at 35,000 x g for 45 min. The Percoll enriched insulin granule fraction was recovered and washed three times with SMT to eliminate colloidal particles of Percoll.

Transmission Electron Microscopy—
Fixation of the ISG pellet was performed by incubation in 2.5% glutaraldehyde for 1 h. The fixed pellet was washed three times with PBS, dehydrated, embedded in epoxy resin, and processed for electron microscopy as described previously (23). Ultrathin sections were contrasted with uranyl acetate and lead citrate and observed with a Technai 20 (FEI Co., Eindhoven, Netherlands) electron microscope.

Protein Separation by SDS-PAGE—
Prior to SDS-PAGE, proteins were quantified using a Bradford assay (Bio-Rad). Equal amounts of proteins from the total cells and from the different cellular fractions were solubilized in sample buffer (62.5 mM Tris-HCl, pH 6.8, 1% (w/v) SDS, 10% (v/v) glycerol, 0.1 M dithiothreitol, and traces of bromphenol blue) before separation on a 12.5% T, 2.6% C polyacrylamide gel (71). After electrophoresis proteins were stained with Coomassie Blue R-250 (Merck).

Immunoblotting—
Seven micrograms of protein from each cellular fraction was separated by SDS-PAGE and transferred onto polyvinylidene difluoride membrane (Bio-Rad). Immunoreactive bands were revealed by enhanced chemiluminescence using horseradish peroxidase-coupled secondary antibodies (1:2000) (Roche Applied Science).

Protein Identification by LC-MS/MS—
A 1-DE gel lane corresponding to insulin secretory granules was cut in 28 consecutive pieces of gel. For each piece of gel "in-gel" digestion was performed as described by Scherl et al. (24). LC-MS/MS analysis with the LCQ ion trap (Thermo Finnigan, San Jose, CA) was performed as described by Burgess et al. (25). Peak lists were generated using Bioworks 3.1 software (Thermo Finnigan). The resulting .dta files from each analysis were automatically combined into a single text file. The resulting peak lists were searched against the rat International Protein Index (IPI) database version 3.20 (41,546 entries, European Bioinformatics Group) using Mascot operating on a local server (version 2.1, Matrix Science) and Phenyx (GeneBio). Mascot was used with average mass selected, a precursor mass error of 2.0 Da, and a peptide mass error of 1.0 Da. Trypsin was selected as the enzyme with three potential missed cleavages. ESI ion trap was selected as the instrument type, and oxidized methionine and carbamidomethylated cysteine were selected as variable modifications. For Phenyx, ion trap was selected for the instrument type, and LCQ was selected for the algorithm. Two search rounds were used, both with trypsin selected as the enzyme and oxidized methionine and carbamidomethylated cysteine selected as variable modifications. In the first round one missed cleavage was allowed, and the normal cleavage mode was used. This round was selected in "turbo" search mode. In the second round three missed cleavages were allowed, and the cleavage mode was set to half-cleaved. The minimum peptide length allowed was 6 amino acids, and the parent ion tolerance was 2.0 Da in both search rounds. The acceptance criteria were slightly lowered in the second round search (round 1: AC score, 7.0; peptide Z-score, 7.0; peptide p value, 1E–7; round 2: AC score, 7.0; peptide Z-score, 6.0; peptide p value, 1E–6). Only proteins that were identified with one or more high scoring peptides from both Mascot and Phenyx were considered to be true matches. "High scoring peptides" corresponded to peptides that were above the threshold in Mascot (p < 0.05) and Phenyx (p value >1E–7) searches. Peptides common to different proteins are in italic in Supplemental Table 2. All identified proteins were manually confirmed to contain at least one specific and non-redundant peptide.

Immunocytochemistry—
INS-1E cells cultured on coverslips were fixed for 20 min in 3% (w/v) paraformaldehyde in PBS, washed three times with PBS, and exposed for 20 min in 50 mM NH4Cl to avoid autofluorescence. Cells were then washed three times with PBS, blocked for 15 min in 10% FCS, and exposed for 45 min in PBS containing primary antibodies, 0.1% saponin, and 10% FCS. Cells were then exposed to fluorescent dye-conjugated secondary antibodies (1:100) for 30 min at room temperature. Samples were analyzed using a Zeiss laser confocal microscope (LSM 510 Meta, Carl Zeiss AG, Zurich, Switzerland). Images were taken with a 60x objective.


   RESULTS
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Efficiency of the Subcellular Fractionation—
Efficient organelle proteomics analysis always depends on the quality of subcellular fractionation and organelle enrichment. Here the common continuous sucrose density gradient (0.45–2 M) permitted the separation of the two vesicular populations in INS-1 cells: ISGs and synaptic-like microvesicles (26). However, Western blot analyses of the obtained ISG fractions revealed the presence of calreticulin, indicating an ER contamination (data not shown). Therefore, we established a two-step subcellular fractionation protocol, which is composed of an initial discontinuous Nycodenz gradient followed by a 27% Percoll solution (Fig. 1A). To determine the enriched ISG fraction in the Nycodenz gradient, insulin was quantified in 12 fractions. Fraction 8 exhibited the largest level of insulin (Fig. 1B, left panel). Western blotting performed with antibodies against betagranin (N-terminal fragment of chromogranin A) or calreticulin (ER-resident protein) showed that fraction 8 contains higher levels of betagranin and lower levels of calreticulin (Fig. 1B, right panel). Thus, fraction 8 was chosen for subsequent separation on a Percoll solution. Analysis of the different fractions showed that in fraction 12 of this Percoll solution calreticulin was absent, whereas insulin and betagranin were present in high amounts (Fig. 1C). This fraction, referred to as the ISG fraction, was selected for subsequent proteomics analysis.


Figure 1
View larger version (14K):
[in this window]
[in a new window]

  		FIG. 1. A, schematic to illustrate the isolation of ISGs from INS-1E cells. B, left, insulin quantification in each of 12 fractions obtained from the Nycodenz gradient. Right, Western blot analysis of Nycodenz fractions 6–12 with an antibody directed to calreticulin (Cal) and to betagranin (Bg). C, left, insulin was quantified in each of 12 fractions obtained from the Percoll cushion. Right, Western blot analysis of Percoll fractions 6–12 with an antibody directed to calreticulin (Cal) and to betagranin (Bg).

 
Subcellular Fractionation Validation by 1-DE Gels, Immunoblotting, and Electron Microscopy—
To evaluate the ISG enrichment, 25 µg of proteins from each cellular fraction was separated by SDS-PAGE and stained with Coomassie Blue (Fig. 2A). The band patterns obtained from total cells, PNS, and cytoplasmic fractions were very similar. However, the band pattern of the ISG fraction was clearly different. Similar results were observed by silver staining (data not shown). These data demonstrate that this fraction is highly enriched in specific proteins.


Figure 2
View larger version (38K):
[in this window]
[in a new window]

  		FIG. 2. A, insulin secretory granule protein separation by SDS-PAGE. Shown is the 1-DE separation of proteins extracted from total cells (TC) and from subcellular fractions as indicated on the top of the gel (C, cytoplasm). Each fraction (25 µg of proteins) was separated on a 12.5% polyacrylamide gel and stained with Coomassie Brilliant Blue R-250. B, immunoblotting assessment of insulin secretory granule enrichment. Western blot analyses of total cells (TC), PNS, cytoplasm (C), and ISGs using antibodies against betagranin, calreticulin, GS28, ERK2, Glut2, LaminB, Rab5, GDH, cathepsin D, and Lamp2. Each lane was loaded with 7 µg of proteins. C, a, representative electron micrograph of an ISG-enriched fraction. The insulin secretory granule fraction purified from INS-1E cells was fixed and processed for electron microscopy analysis as described under "Experimental Procedures." Scale bar, 500 nm. b, magnified image of the boxed area.

 
To further investigate the enrichment of the ISG preparation, we performed Western blotting using antibodies against markers of various cellular compartments such as ISG (betagranin), endoplasmic reticulum (calreticulin), Golgi network (GS28), cytoplasm (ERK2), plasma membrane (Glut2), nucleus (LaminB), late endosome (Rab5), mitochondria (GDH), and lysosomes (Cathepsin D and Lamp2) (Fig. 2B). Betagranin, used as a positive control, was mainly recovered in the ISG fraction. In contrast, except Cathepsin D and Lamp2, the tested markers were absent or barely detectable (Rab5 and GDH) in the ISG fraction, indicating only minor contamination.

Consistent with these data, electron microscopy analysis revealed that the ISG fraction was highly enriched in ISGs. Furthermore ISGs maintained an intact morphology with the typical insulin dense core surrounded by filamentous structures (Fig. 2C) (27).

Separation and Identification of ISG Proteins—
To characterize the ISG proteome, 28 consecutive SDS-PAGE gel bands were cut from the insulin granule lane (Fig. 3). LC-MS/MS identified 130 rat proteins (Table I and Supplemental Table 2). According to the literature we grouped the identified proteins in four structural classes as follows (Fig. 4): C1, intravesicular proteins (n = 57) such as chromogranin A (28), betagranin (29), or insulin (30); C2, membrane proteins (n = 59) including cysteine string protein (12), Rab3a, -b, -c, and -d (26), granuphilin (31), or VAMP2 and -3 (14); C3, novel proteins (n = 4) that are a small number of proteins with unpredictable function and cellular location; and C4, other proteins (n = 10) represented by proteins with various functions not previously described in insulin-secreting cells.


Figure 3
View larger version (18K):
[in this window]
[in a new window]

  		FIG. 3. The insulin secretory granule lane was cut in 28 consecutive gel pieces for protein analysis by mass spectrometry.

 

View this table:
[in this window]
[in a new window]

  		TABLE I Proteins identified in insulin secretory granules by LC-MS/MS analysis

GM2, GalNAcß 4(Neu5Ac{alpha} 3)Galß 4GlcCer; SPARC, secreted protein acidic and rich in cysteine; ADAM, a disintegrin and metalloproteinase; GLI, glioma.

 

Figure 4
View larger version (17K):
[in this window]
[in a new window]

  		FIG. 4. Illustration in four functional classes of the 130 insulin granule proteins identified in this study. See the list in Supplemental Table 2. The number (n) and the percentage of each class are shown.

 
Immunocytochemistry Validation—
Because numerous lysosomal hydrolases were identified in the C1 class, we first evaluated the cellular distribution of cathepsin B, D, and L by immunofluorescence in INS-1E cells (Fig. 5). Confocal microscopy images showed that all three isoforms are expressed in compartments containing immunoreactive insulin. These proteins were also detected in nuclear near regions devoid of insulin (Fig. 5, A–C).


Figure 5
View larger version (32K):
[in this window]
[in a new window]

  		FIG. 5. Intracellular localization of cathepsins. INS-1E cells were analyzed by confocal microscopy after double labeling with an antibody against insulin and with cathepsin B (CatB), cathepsin L (CatL), or cathepsin D (CatD) antibodies; the cells were then exposed to FITC- or rhodamine-conjugated secondary antibodies. Merged images are shown in the right panels.

 
Regarding the C2 class, we next assessed the distribution of the Lamp2. Consistent with cathepsin localization, Lamp2 was observed in both areas close to the membrane containing insulin and in the perinuclear region without the hormone (Fig. 6A).


Figure 6
View larger version (41K):
[in this window]
[in a new window]

  		FIG. 6. Subcellular distribution of Lamp2, VAMP8, and Rab37. A and B, INS-1E cells were double labeled with an antibody directed to insulin together with anti-Lamp2 or anti-VAMP8 and further exposed to FITC- or rhodamine-conjugated secondary antibodies. C, EGFP-Rab37 was transiently transfected in INS-1E cells. Three days later the cells were stained with an anti-insulin antibody coupled to rhodamine. Overlapping images are shown in the right panels.

 
Because the C2 class contains numerous vesicle-associated proteins including Rabs and VAMPs, we focused on Rab37 and VAMP8. Double labeling experiments showed that VAMP8 mainly colocalizes to ISGs (Fig. 6B); the protein was also concentrated in perinuclear organelles devoid of insulin. Given that Rab37 antibody was not appropriate for immunofluorescence studies, we transiently overexpressed EGFP-tagged Rab37 in INS-1E cells. Fig. 6C shows that EGFP-Rab37 was predominantly associated with ISGs.


   DISCUSSION
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Isolation of Insulin Secretory Granules
Subcellular fractionation has been widely used for proteomics analyses of different intracellular organelles and complexes such as mitochondria (32), Golgi network (33), lysosome (34), phagosome (35), endosome (36), peroxisome (37), or nucleoli (38). The main inconvenience of this approach is the potential presence of other subcellular structures that could share similar physical properties and comigrate in density gradients. Therefore, a complete purification of an organelle by subcellular fractionation is hardly possible. However, this approach is still the most efficient strategy to obtain enriched organelles of interest for further proteome studies (39). Regarding ISG purification, we first tested a continuous sucrose density gradient (0.45–2 M) that showed a poor separation of ISGs from the endoplasmic reticulum. Therefore, a two-step fractionation strategy with an initial gradient of Nycodenz followed by a Percoll solution was applied. This method generated a highly enriched fraction of ISG proteins as demonstrated by Western blot and electron microscopy experiments.

Proteomics of Insulin Secretory Granules
To date about 30 proteins have been reported as being associated with insulin granules. However, Guest et al. (40) have shown that a few hundred polypeptides could be detected by 2-DE gel analyses of an enriched ISG fraction. The main disadvantage of using 2-DE gels is the inability to analyze membrane proteins, which could be of primary importance in vesicles such as ISGs. In contrast, 1-DE gels coupled to liquid chromatography permitted a good extraction and separation of both soluble and insoluble proteins (24) and was therefore used in the present study. MS analyses were performed on the tryptic digests coming from 28 consecutive gel slices. This strategy identified 130 different proteins. Twenty of them have been reported previously to colocalize with ISGs, whereas further validation is required for the remaining 110.

The Structural Classification of ISG Proteins
According to the literature we could group the identified proteins in four structural classes: C1, intravesicular proteins (n = 57); C2, membrane proteins (n = 59); C3, novel proteins (n = 4); and C4, other proteins (n = 10). These four classes are discussed below.

Intravesicular Proteins—
A large fraction of the 57 proteins is represented by secreted proteins (n = 18), which include insulin, chromogranin A, betagranin, and secretogranin. A substantial number of proteins are represented by hydrolases (n = 33) including different forms of cathepsin (B, D, and L) or glucuronidase. By immunofluorescence experiments, we located cathepsin B, D, and L in ISGs and in other vesicles most likely corresponding to lysosome. Several authors (18, 41) have previously described the presence of hydrolases within ISGs. Kuliawat et al. (42) showed by electron microscopy that both cathepsins B and L are present in immature ß-granules, whereas only the immunolabeling for cathepsin L (but not B) persists in mature granules. The authors could demonstrate that the sorting of these enzymes from the immature granules follows the same mechanisms as that in lysosomes, i.e. involving the mannose 6-phosphate receptor. These results might be consistent with the "sorting by retention" hypothesis in primary ß-cells (43). In this hypothesis the immature secretory granules are the sorting point for proteins targeted either to mature granules or to lysosomes. On the contrary, in the "sorting for entry" hypothesis, the trans-Golgi network is the unique sorting point for ISG proteins and for proteins of other organelles (44). Alternatively to the above hypothesis, lysosomal proteins could come from the crinophagy process. Effectively the insulin content of ß-cells is balanced through its biosynthesis, secretion, and degradation. Intracellular degradation of insulin is performed by crinophagy through the fusion of secretory granules with lysosomes (45). The three alternative hypotheses are not exclusive because it is possible that the sorting by retention hypothesis only occurs in cells having regulated secretion such as ß-cells (43). All together our results strongly support the sorting by retention hypothesis. Further enrichment of immature secretory granules will be required to investigate the role of well selected hydrolases in the early biogenesis of ISGs.

Membrane Proteins—
A second large class of identified proteins is represented by membrane or membrane-associated proteins (n = 59). We identified 14 different Rab proteins. Rabs are monomeric GTPases of the Ras superfamily that regulate different steps of vesicular trafficking. Although the role of Rab proteins in vesicle fusion is fairly well recognized, the precise task of such Rabs in transport is still unknown (46). Among these proteins only the Rab3 isoforms (26) and Rab27a (47) were shown to be associated with ISGs. Both proteins are involved in the regulation of insulin exocytosis together with their specific effectors such as Noc2, granuphilin, or the Rab3-interacting molecule RIM (48–51). Among the 14 Rabs, we identified Rab12, which is associated with secretory granules of atrial myocytes and Sertoli cells (52, 53), as well as Rab37, which is found on secretory granules in mast cells (54). Our immunofluorescence experiments revealed that overexpressed EGFP-Rab37 is associated with ISGs in INS-1E cells suggesting its functional role in the regulation of insulin secretion.

The VAMPs are members of the v-SNARE family, which participates in diverse intracellular docking/fusion events by pairing with their cognate t-SNAREs on the target membrane (55). We identified four VAMPs. VAMP2 and -3 are associated with ISGs (14), whereas VAMP7 and -8 are colocalized with late endosomes (56) and to zymogen granules of pancreatic acinar cells (57), respectively. Our confocal microscopy analysis demonstrated that VAMP8 is located on ISGs and other organelles probably corresponding to early endosomes as reported for the insulinoma MIN6 (57). We found other membrane proteins involved in the regulated exocytosis such as synaptotagmin 5 or annexin A4 as well as different forms of the vacuolar ATPase or voltage-dependent anion channel.

The finding of known lysosomal proteins in our preparation was not limited to hydrolases because Lamp2, a lysosome-associated membrane protein, was identified as well. Using immunofluorescence, Lamp2 was detected on ISGs and other vesicular structures corresponding most likely to lysosomes.

Novel Proteins—
For four of the 130 identified proteins we could not assign any biological function using sequence similarities, domain composition, or pathway information.

Other Proteins—
Finally the function of a relative small proportion (n = 10) of identified proteins like the fructose-bisphosphate aldolase A or the peptidyl-prolyl cis-trans isomerase A has never been described in ß-cells. Therefore, the validation and the association of these proteins with ISGs should be further investigated.

In conclusion, the present proteomics analysis of ISGs revealed 130 proteins. Confocal microscopy analysis of some selected proteins demonstrated their presence on ISGs. The validation of hydrolases and lysosomal proteins within ISGs supports the sorting by retention hypothesis. The association of Rab37 and VAMP8 proteins with ISGs was also highlighted for the first time suggesting an even more complex mechanism for vesicle trafficking than described previously in ß-cells. In summary, these results clearly demonstrate that our strategy has determined a new subset of insulin secretory granule proteins that will further help to unravel the complex molecular anatomy and functional structure of insulin secretory granules.


   ACKNOWLEDGMENTS
 
We thank Alexandre Hainard and Véronique Converset for technical assistance.


  FOOTNOTES
 
Received, November 20, 2006, and in revised form, February 20, 2007.

Published, MCP Papers in Press, February 22, 2007, DOI 10.1074/mcp.M600443-MCP200

1 The abbreviations used are: ER, endoplasmic reticulum; EGFP, enhanced green fluorescent protein; GDH, glutamate dehydrogenase; ISG, insulin secretory granule; Lamp, lysosome-associated membrane protein; PNS, postnuclear supernatant; SMT, sucrose-MOPS-Tris; Rab, Ras-associated bovine protein; VAMP, vesicle-associated membrane protein; 1-DE, one-dimensional gel electrophoresis; 2-DE, two-dimensional gel electrophoresis; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; v-SNARE, vesicle-associated SNARE; t-SNARE, target membrane SNARE. Back

* This work was supported by Swiss National Fund Grant 3100A0-104214. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

S The on-line version of this article (available at http://www.mcponline.org) contains supplemental material. Back

** To whom correspondence should be addressed: Biomedical Proteomics Research Group, DBSB/CMU, Rue Michel Servet 1, CH-1211 Genève 4, Switzerland. Tel.: 41-22-379-54-86; Fax: 41-22-379-59-84; E-mail: Jean-Charles.Sanchez{at}medecine.unige.ch


   REFERENCES
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Saltiel, A. R. (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104, 517 –529[CrossRef][Medline]

  2. Bhathena, S. J. (2006) Relationship between fatty acids and the endocrine and neuroendocrine system. Nutr. Neurosci. 9, 1 –10[CrossRef][Medline]

  3. Proud, C. G. (2006) Regulation of protein synthesis by insulin. Biochem. Soc. Trans. 34, 213 –216[CrossRef][Medline]

  4. Revill, P., Moral, M. A., and Prous, J. R. (2006) Impaired insulin signaling and the pathogenesis of Alzheimer's disease. Drugs Today (Barc.) 42, 785 –790[CrossRef][Medline]

  5. Marshall, S. (2006). Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci. STKE 2006, re7[Abstract/Free Full Text]

  6. Kulkarni, R. N. (2004) The islet beta-cell. Int. J. Biochem. Cell Biol. 36, 365 –371[CrossRef][Medline]

  7. Lang, J. (1999) Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur. J. Biochem. 259, 3 –17[Medline]

  8. Klumperman, J., Kuliawat, R., Griffith, J. M., Geuze, H. J., and Arvan, P. (1998) Mannose 6-phosphate receptors are sorted from immature secretory granules via adaptor protein AP-1, clathrin, and syntaxin 6-positive vesicles. J. Cell Biol. 141, 359 –371[Abstract/Free Full Text]

  9. Barg, S., Huang, P., Eliasson, L., Nelson, D. J., Obermuller, S., Rorsman, P., Thevenod, F., and Renstrom, E. (2001) Priming of insulin granules for exocytosis by granular Cl– uptake and acidification. J. Cell Sci. 114, 2145 –2154[Abstract/Free Full Text]

  10. Molinete, M., Irminger, J. C., Tooze, S. A., and Halban, P. A. (2000) Trafficking/sorting and granule biogenesis in the beta-cell. Semin. Cell Dev. Biol. 11, 243 –251[CrossRef][Medline]

  11. Rorsman, P., and Renstrom, E. (2003) Insulin granule dynamics in pancreatic beta cells. Diabetologia 46, 1029 –1045[CrossRef][Medline]

  12. Brown, H., Larsson, O., Branstrom, R., Yang, S. N., Leibiger, B., Leibiger, I., Fried, G., Moede, T., Deeney, J. T., Brown, G. R., Jacobsson, G., Rhodes, C. J., Braun, J. E., Scheller, R. H., Corkey, B. E., Berggren, P. O., and Meister, B. (1998) Cysteine string protein (CSP) is an insulin secretory granule-associated protein regulating beta-cell exocytosis. EMBO J. 17, 5048 –5058[CrossRef][Medline]

  13. Easom, R. A. (2000) Beta-granule transport and exocytosis. Semin. Cell Dev. Biol. 11, 253 –266[CrossRef][Medline]

  14. Regazzi, R., Wollheim, C. B., Lang, J., Theler, J. M., Rossetto, O., Montecucco, C., Sadoul, K., Weller, U., Palmer, M., and Thorens, B. (1995) VAMP-2 and cellubrevin are expressed in pancreatic beta-cells and are essential for Ca2+- but not for GTP{gamma}S-induced insulin secretion. EMBO J. 14, 2723 –2730[Medline]

  15. Yaekura, K., Julyan, R., Wicksteed, B. L., Hays, L. B., Alarcon, C., Sommers, S., Poitout, V., Baskin, D. G., Wang, Y., Philipson, L. H., and Rhodes, C. J. (2003) Insulin secretory deficiency and glucose intolerance in Rab3A null mice. J. Biol. Chem. 278, 9715 –9721[Abstract/Free Full Text]

  16. Gerich, J. E. (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 19, 491 –503[Abstract/Free Full Text]

  17. Taylor, S. I. (1999) Deconstructing type 2 diabetes. Cell 97, 9 –12[CrossRef][Medline]

  18. Hutton, J. C. (1994) Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases. Diabetologia 37, Suppl. 2, S48 –S56

  19. Iezzi, M., Kouri, G., Fukuda, M., and Wollheim, C. B. (2004) Synaptotagmin V and IX isoforms control Ca2+-dependent insulin exocytosis. J. Cell Sci. 117, 3119 –3127[Abstract/Free Full Text]

  20. Iezzi, M., Eliasson, L., Fukuda, M., and Wollheim, C. B. (2005) Adenovirus-mediated silencing of synaptotagmin 9 inhibits Ca2+-dependent insulin secretion in islets. FEBS Lett. 579, 5241 –5246[CrossRef][Medline]

  21. Merglen, A., Theander, S., Rubi, B., Chaffard, G., Wollheim, C. B., and Maechler, P. (2004) Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145, 667 –678[Abstract/Free Full Text]

  22. Tsuboi, T., and Fukuda, M. (2006) Rab3A and Rab27A cooperatively regulate the docking step of dense-core vesicle exocytosis in PC12 cells. J. Cell Sci. 119, 2196 –2203[Abstract/Free Full Text]

  23. Foti, M., Phelouzat, M. A., Holm, A., Rasmusson, B. J., and Carpentier, J. L. (2002) p56Lck anchors CD4 to distinct microdomains on microvilli. Proc. Natl. Acad. Sci. U. S. A. 99, 2008 –2013[Abstract/Free Full Text]

  24. Scherl, A., Coute, Y., Deon, C., Calle, A., Kindbeiter, K., Sanchez, J. C., Greco, A., Hochstrasser, D., and Diaz, J. J. (2002) Functional proteomic analysis of human nucleolus. Mol. Biol. Cell 13, 4100 –4109[Abstract/Free Full Text]

  25. Burgess, J. A., Lescuyer, P., Hainard, A., Burkhard, P. R., Turck, N., Michel, P., Rossier, J. S., Reymond, F., Hochstrasser, D. F., and Sanchez, J. C. (2006) Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid. J. Proteome Res. 5, 1674 –1681[CrossRef][Medline]

  26. Iezzi, M., Escher, G., Meda, P., Charollais, A., Baldini, G., Darchen, F., Wollheim, C. B., and Regazzi, R. (1999) Subcellular distribution and function of Rab3A, B, C, and D isoforms in insulin-secreting cells. Mol. Endocrinol. 13, 202 –212[Abstract/Free Full Text]

  27. Orci, L., Ravazzola, M., Amherdt, M., Madsen, O., Vassalli, J. D., and Perrelet, A. (1985) Direct identification of prohormone conversion site in insulin-secreting cells. Cell 42, 671 –681[CrossRef][Medline]

  28. Ehrhart, M., Grube, D., Bader, M. F., Aunis, D., and Gratzl, M. (1986) Chromogranin A in the pancreatic islet: cellular and subcellular distribution. J. Histochem. Cytochem. 34, 1673 –1682[Abstract]

  29. Hutton, J. C., Peshavaria, M., Johnston, C. F., Ravazzola, M., and Orci, L. (1988) Immunolocalization of betagranin: a chromogranin A-related protein of the pancreatic B-cell. Endocrinology 122, 1014 –1020[Abstract]

  30. Coore, H. G., Hellman, B., Pihl, E., and Taljedal, I. B. (1969) Physicochemical characteristics of insulin secretion granules. Biochem. J. 111, 107 –113[Medline]

  31. Gomi, H., Mizutani, S., Kasai, K., Itohara, S., and Izumi, T. (2005) Granuphilin molecularly docks insulin granules to the fusion machinery. J. Cell Biol. 171, 99 –109[Abstract/Free Full Text]

  32. Da Cruz, S., Xenarios, I., Langridge, J., Vilbois, F., Parone, P. A., and Martinou, J. C. (2003) Proteomic analysis of the mouse liver mitochondrial inner membrane. J. Biol. Chem. 278, 41566 –41571[Abstract/Free Full Text]

  33. Takatalo, M. S., Kouvonen, P., Corthals, G., Nyman, T. A., and Ronnholm, R. H. (2006) Identification of new Golgi complex specific proteins by direct organelle proteomic analysis. Proteomics 6, 3502 –3508[CrossRef][Medline]

  34. Bagshaw, R. D., Mahuran, D. J., and Callahan, J. W. (2005) A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle. Mol. Cell. Proteomics 4, 133 –143[Abstract/Free Full Text]

  35. Garin, J., Diez, R., Kieffer, S., Dermine, J. F., Duclos, S., Gagnon, E., Sadoul, R., Rondeau, C., and Desjardins, M. (2001) The phagosome proteome: insight into phagosome functions. J. Cell Biol. 152, 165 –180[Abstract/Free Full Text]

  36. Girard, M., Poupon, V., Blondeau, F., and McPherson, P. S. (2005) The DnaJ-domain protein RME-8 functions in endosomal trafficking. J. Biol. Chem. 280, 40135 –40143[Abstract/Free Full Text]

  37. Ofman, R., Speijer, D., Leen, R., and Wanders, R. J. (2006) Proteomic analysis of mouse kidney peroxisomes: identification of RP2p as a peroxisomal nudix hydrolase with acyl-CoA diphosphatase activity. Biochem. J. 393, 537 –543[CrossRef][Medline]

  38. Coute, Y., Burgess, J. A., Diaz, J. J., Chichester, C., Lisacek, F., Greco, A., and Sanchez, J. C. (2006) Deciphering the human nucleolar proteome. Mass Spectrom. Rev. 25, 215 –234[CrossRef][Medline]

  39. Chen, E. I., Hewel, J., Felding-Habermann, B., and Yates, J. R., III (2006) Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol. Cell. Proteomics 5, 53 –56[Abstract/Free Full Text]

  40. Guest, P. C., Bailyes, E. M., Rutherford, N. G., and Hutton, J. C. (1991). Insulin secretory granule biogenesis. Co-ordinate regulation of the biosynthesis of the majority of constituent proteins. Biochem. J. 274, 73 –78[Medline]

  41. Davidson, H. W., and Hutton, J. C. (1987) The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochem. J. 245, 575 –582[Medline]

  42. Kuliawat, R., Klumperman, J., Ludwig, T., and Arvan, P. (1997) Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic beta-cells. J. Cell Biol. 137, 595 –608[Abstract/Free Full Text]

  43. Arvan, P., and Castle, D. (1998). Sorting and storage during secretory granule biogenesis: looking backward and looking forward. Biochem. J. 332, 593 –610[Medline]

  44. Tooze, S. A. (1998) Biogenesis of secretory granules in the trans-Golgi network of neuroendocrine and endocrine cells. Biochim. Biophys. Acta 1404, 231 –244[Medline]

  45. Sandberg, M., and Borg, L. A. H. (2006) Intracellular degradation of insulin and crinophagy are maintained by nitric oxide and cyclo-oxygenase 2 activity in isolated pancreatic islets. Biol. Cell 98, 307 –315[CrossRef][Medline]

  46. Jordens, I., Marsman, M., Kuijl, C., and Neefjes, J. (2005) Rab proteins, connecting transport and vesicle fusion. Traffic 6, 1070 –1077[CrossRef][Medline]

  47. Waselle, L., Coppola, T., Fukuda, M., Iezzi, M., El-Amraoui, A., Petit, C., and Regazzi, R. (2003) Involvement of the Rab27 binding protein Slac2c/MyRIP in insulin exocytosis. Mol. Biol. Cell 14, 4103 –4113[Abstract/Free Full Text]

  48. Cheviet, S., Coppola, T., Haynes, L. P., Burgoyne, R. D., and Regazzi, R. (2004) The Rab-binding protein Noc2 is associated with insulin-containing secretory granules and is essential for pancreatic beta-cell exocytosis. Mol. Endocrinol. 18, 117 –126[Abstract/Free Full Text]

  49. Torii, S., Takeuchi, T., Nagamatsu, S., and Izumi, T. (2004) Rab27 effector granuphilin promotes the plasma membrane targeting of insulin granules via interaction with syntaxin 1a. J. Biol. Chem. 279, 22532 –22538[Abstract/Free Full Text]

  50. Wang, Y., Okamoto, M., Schmitz, F., Hofmann, K., and Sudhof, T. C. (1997) Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion. Nature 388, 593 –598[CrossRef][Medline]

  51. Iezzi, M., Regazzi, R., and Wollheim, C. B. (2000) The Rab3-interacting molecule RIM is expressed in pancreatic beta-cells and is implicated in insulin exocytosis. FEBS Lett. 474, 66 –70[CrossRef][Medline]

  52. Iida, H., Wang, L., Nishii, K., Ookuma, A., and Shibata, Y. (1996) Identification of rab12 as a secretory granule-associated small GTP-binding protein in atrial myocytes. Circ. Res. 78, 343 –347[Abstract/Free Full Text]

  53. Iida, H., Noda, M., Kaneko, T., Doiguchi, M., and Mori, T. (2005) Identification of rab12 as a vesicle-associated small GTPase highly expressed in Sertoli cells of rat testis. Mol. Reprod. Dev. 71, 178 –185[CrossRef][Medline]

  54. Masuda, E. S., Luo, Y., Young, C., Shen, M., Rossi, A. B., Huang, B. C., Yu, S., Bennett, M. K., Payan, D. G., and Scheller, R. H. (2000) Rab37 is a novel mast cell specific GTPase localized to secretory granules. FEBS Lett. 470, 61 –64[CrossRef][Medline]

  55. Lin, R. C., and Scheller, R. H. (2000) Mechanisms of synaptic vesicle exocytosis. Annu. Rev. Cell Dev. Biol. 16, 19 –49[CrossRef][Medline]

  56. Pryor, P. R., Mullock, B. M., Bright, N. A., Lindsay, M. R., Gray, S. R., Richardson, S. C., Stewart, A., James, D. E., Piper, R. C., and Luzio, J. P. (2004) Combinatorial SNARE complexes with VAMP7 or VAMP8 define different late endocytic fusion events. EMBO Rep. 5, 590 –595[CrossRef][Medline]

  57. Nagamatsu, S., Nakamichi, Y., Watanabe, T., Matsushima, S., Yamaguchi, S., Ni, J., Itagaki, E., and Ishida, H. (2001) Localization of cellubrevin-related peptide, endobrevin, in the early endosome in pancreatic beta cells and its physiological function in exo-endocytosis of secretory granules. J. Cell Sci. 114, 219 –227[Abstract]

  58. Rindler, M. J. (1998) Carboxypeptidase E, a peripheral membrane protein implicated in the targeting of hormones to secretory granules, co-aggregates with granule content proteins at acidic pH. J. Biol. Chem. 273, 31180 –31185[Abstract/Free Full Text]

  59. Itoh, Y., Tanaka, S., Takekoshi, S., Itoh, J., and Osamura, R. Y. (1996) Prohormone convertases (PC1/3 and PC2) in rat and human pancreas and islet cell tumors: subcellular immunohistochemical analysis. Pathol. Int. 46, 726 –737[Medline]

  60. Guest, P. C., Rhodes, C. J., and Hutton, J. C. (1989) Regulation of the biosynthesis of insulin-secretory-granule proteins. Co-ordinate translational control is exerted on some, but not all, granule matrix constituents. Biochem. J. 257, 431 –437[Medline]

  61. Paronen, J., Moriyama, H., Abiru, N., Sikora, K., Melanitou, E., Babu, S., Bao, F., Liu, E., Miao, D., and Eisenbarth, G. S. (2003) Establishing insulin 1 and insulin 2 knockout congenic strains on NOD genetic background. Ann. N. Y. Acad. Sci. 1005, 205 –210[CrossRef][Medline]

  62. Devendra, D., Paronen, J., Moriyama, H., Miao, D., Eisenbarth, G. S., and Liu, E. (2004) Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes. J. Autoimmun. 23, 17 –26[CrossRef][Medline]

  63. Howell, S. L., Young, D. A., and Lacy, P. E. (1969) Isolation and properties of secretory granules from rat islets of Langerhans. 3. Studies of the stability of the isolated beta granules. J. Cell Biol. 41, 167 –176[Abstract/Free Full Text]

  64. Portela-Gomes, G. M., and Stridsberg, M. (2002) Region-specific antibodies to chromogranin B display various immunostaining patterns in human endocrine pancreas. J. Histochem. Cytochem. 50, 1023 –1030[Abstract/Free Full Text]

  65. Lukinius, A., Wilander, E., Eriksson, B., and Oberg, K. (1992) A chromogranin peptide is co-stored with insulin in the human pancreatic islet B-cell granules. Histochem. J. 24, 679 –684[CrossRef][Medline]

  66. Hosaka, M., Watanabe, T., Sakai, Y., Kato, T., and Takeuchi, T. (2005) Interaction between secretogranin III and carboxypeptidase E facilitates prohormone sorting within secretory granules. J. Cell Sci. 118, 4785 –4795[Abstract/Free Full Text]

  67. Hosaka, M., Watanabe, T., Sakai, Y., Uchiyama, Y., and Takeuchi, T. (2002) Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells. Mol. Biol. Cell 13, 3388 –3399[Abstract/Free Full Text]

  68. Cheviet, S., Bezzi, P., Ivarsson, R., Renstrom, E., Viertl, D., Kasas, S., Catsicas, S., and Regazzi, R. (2006) Tomosyn-1 is involved in a post-docking event required for pancreatic beta-cell exocytosis. J. Cell Sci. 119, 2912 –2920[Abstract/Free Full Text]

  69. Bright, N. A., Walters, J., Wasmeier, C., and Hutton, J. C. (2002). Targeting of a phogrin-green fluorescent protein chimaera to insulin secretory granules of pancreatic beta-cells in transgenic mice. Diabetes Metab. 28, 3S29 –3S36; discussion 3S108–3S112[Medline]

  70. Arden, C., Harbottle, A., Baltrusch, S., Tiedge, M., and Agius, L. (2004) Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation. Diabetes 53, 2346 –2352[Abstract/Free Full Text]

  71. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680 –685[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 EndocrinologyHome page
F. Xia, L. Xie, A. Mihic, X. Gao, Y. Chen, H. Y. Gaisano, and R. G. Tsushima
Inhibition of Cholesterol Biosynthesis Impairs Insulin Secretion and Voltage-Gated Calcium Channel Function in Pancreatic {beta}-Cells
Endocrinology, October 1, 2008; 149(10): 5136 - 5145.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
S. L. Schwartz, C. Cao, O. Pylypenko, A. Rak, and A. Wandinger-Ness
Rab GTPases at a glance
J. Cell Sci., November 15, 2007; 120(22): 3905 - 3910.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M600443-MCP200v1
M600443-MCP200v2
6/6/1007    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunner, Y.
Right arrow Articles by Sanchez, J.-C.
Right arrow Searc